Pittsfield, Massachusetts
United States
34
2016-07-21
The entities that hold a legal rights for patent applications filed by inventor Muraca Patrick J.:
Patrick J. Muraca from Pittsfield, US has applied for patents for these inventions. The list has both pending applications and granted patents:
MSIA-SRM ASSAY FOR BIOMARKER ANALYSIS
#2 | 2015-10-29BIOMARKER PANEL FOR PREDICTION OF RECURRENT COLON CANCER
#3 | 2015-08-06USP2A PEPTIDES AND ANTIBODIES
#4 | 2015-07-30Anti-phospho-Akt antibodies
#5 | 2015-05-14MRM-MS SIGNATURE ASSAY
#6 | 2015-02-19PREDICTIVE BIOMARKERS FOR BREAST CANCER
#7 | 2014-12-18MIXED FORMAT MICROARRAYS
#8 | 2014-12-11CONGESTIVE HEART FAILURE BIOMARKERS
#9 | 2014-07-24Antibodies against fatty acid synthase
#10 | 2014-05-08METHOD AND ASSAY FOR DETERMINING FAS EXPRESSION
#11 | 2014-05-08PREDICTIVE BIOMARKERS FOR PROSTATE CANCER
#12 | 2014-03-20GENE EXPRESSION PROFILE FOR THERAPEUTIC RESPONSE TO VEGF INHIBITORS
#13 | 2013-12-19Predictive Markers For Cancer and Metabolic Syndrome
#14 | 2013-11-14USP2A PEPTIDES AND ANTIBODIES
#15 | 2013-09-12USP2A PEPTIDES AND ANTIBODIES
#16 | 2013-09-12USP2A PEPTIDES AND ANTIBODIES
#17 | 2013-05-02USP2a peptides and antibodies
#18 | 2013-04-18PREDICTIVE BIOMARKERS FOR BREAST CANCER
#19 | 2012-10-02Methods of making frozen tissue microarrays
#20 | 2012-06-28Method and assay for determining FAS expression
#21 | 2012-06-14BIOMARKERS FOR PREDICTION OF BREAST CANCER
#22 | 2012-04-19Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors
#23 | 2012-01-26Antibodies against fatty acid synthase
#24 | 2011-08-04Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors
#25 | 2011-03-10Biomarker Panel For Prediction Of Recurrent Colorectal Cancer
#26 | 2010-04-15Anti-phospho-Akt antibodies
#27 | 2009-12-03Gene and protein expression profiles associated with the therapeutic efficacy of irinotecan
#28 | 2009-10-22Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors
#29 | 2009-04-30Kinase peptides and antibodies
#30 | 2009-02-19Gene and protein expression profiles associated with the therapeutic efficacy of irinotecan
#31 | 2008-08-28Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors
#32 | 2008-03-27Gene and protein expression profiles associated with the therapeutic efficacy of irinotecan
#33 | 2006-12-14Kinase peptides and antibodies
#34 | 2006-11-23Antibody protein analysis chip
197587 ⎘